Yia | Contract Alerts
ATT 1 Senior _Advisor_2026_Statement of Work - Biological therapeutics EOC Support- 7571PS27Q00017
In plain English
National Institutes of Health seeks two senior executive consultants to advise on biological therapeutics drug development, serving on an oversight committee in Bethesda, MD. Small businesses only. Fixed-price base year plus two option years. Details are in Attachment 1.
Get alerts like this one More from Health And Human Services, Department Of
Description
COMBINED SYNOPSIS / SOLICITATION (COMPETITIVE) Title: 2 Senior Advisor Consultants for the NINDS BPN -Biologics program External Oversight Committee (EOC) Subject Matter Expert (SME) Services (i) This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with RFO Part 12. This announcement constitutes the only solicitation. Offers are being requested and a separate written solicitation will not be issued. The solicitation number is 7571PS27Q00017 issued as a Request for Quote for 2 Senior Advisor Consultants for the NINDS BPN -Biologics program External Oversight Committee (EOC) Subject Matter Expert (SME) Services The Government reserves the right to make one award, multiple awards, or no awards as a result of this solicitation. This acquisition is set-aside for small business concerns. This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov. The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. (ii) This requirement is for the following services: NINDS is seeking [VW1] 2 Senior Advisor Consultants for the NINDS BPN -Biologics program External Oversight Committee (EOC) Subject Matter Expert (SME) Services. (iii) Description of requirement: The NIH is seeking to procure a highly experienced executive-level, drug discovery and development 2 Senior Advisors with experience in the area of biological therapeutics to provide feedback to the NIH program leadership and technical guidance on drug discovery and development projects within the BPN-Biologics portfolio. The Contractor will serve as a member of the BPN-Biologics External Oversight Committee, which provides strategic guidance on BPN-Biologics projects and on occasion other NIH drug discovery and development programs. See Attachment #1 - Statement of Work (SOW) for more information. (iv) The Government anticipates award of a Fixed Price purchase order for this acquisition, and the anticipated base period of performance is: Base: 11/5/2026 � 11/4/2027 Option Year 1: 11/5/2027 � 11/4/2028 Option Year 2: 11/5/2028 � 11/4/2029 (v) The provisions at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at this address: https:…
Get opportunities like this one every morning.
Yia | Contract Alerts reads every new notice and emails you the matches for your NAICS codes, location and certifications, each with a fit score. 14-day free trial.
Start free